S. Hofmeister

Penetration of bevacizumab through the retina after intravitreal injection in the monkey.

P. Heiduschka, K. Bartz-Schmidt, U. Schraermeyer, 2007, Investigative ophthalmology & visual science.

Immunohistochemical localisation of intravitreally injected bevacizumab at the posterior pole of the primate eye: implication for the treatment of retinal vein occlusion

P. Heiduschka, U. Schraermeyer, S. Julien, 2008, British Journal of Ophthalmology.

BEVACIZUMAB (AVASTIN) DOES NOT HARM RETINAL FUNCTION AFTER INTRAVITREAL INJECTION AS SHOWN BY ELECTRORETINOGRAPHY IN ADULT MICE

P. Heiduschka, K. Bartz-Schmidt, U. Schraermeyer, 2008, Retina.

Melanin Precursor 5,6-Dihydroxyindol: Protective Effects and Cytotoxicity on Retinal Cells in vitro and in vivo

P. Heiduschka, K. Bartz-Schmidt, U. Schraermeyer, 2007, Toxicologic pathology.

Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.

P. Heiduschka, U. Schraermeyer, B. Wissinger, 2010, Investigative ophthalmology & visual science.

Lens Injury Has a Protective Effect on Photoreceptors in the RCS Rat

P. Heiduschka, U. Schraermeyer, D. Fischer, 2013, ISRN ophthalmology.